NCT00319202View on ClinicalTrials.gov

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects

PHASE4TerminatedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

February 29, 2012

Conditions

Glucose IntoleranceObesity

Interventions

DRUG

Candesartan

32 mg/d for 6 months

DRUG

Placebo

Placebo administration for 6 months

Trial Locations (1)

10000

Fundación Cardiovascular de Colombia, Floridablanca

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Fundación Cardiovascular de Colombia

OTHER